IRIS
MERLOTTI, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.367
EU - Europa 4.657
AS - Asia 3.307
SA - Sud America 617
AF - Africa 126
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 15.089
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.272
CN - Cina 1.109
RU - Federazione Russa 1.082
SG - Singapore 1.073
GB - Regno Unito 795
IE - Irlanda 735
BR - Brasile 512
IT - Italia 399
UA - Ucraina 389
SE - Svezia 335
VN - Vietnam 329
FR - Francia 310
HK - Hong Kong 263
DE - Germania 262
KR - Corea 170
FI - Finlandia 160
IN - India 89
ZA - Sudafrica 66
CA - Canada 50
AR - Argentina 45
BD - Bangladesh 42
ES - Italia 36
TR - Turchia 36
NL - Olanda 33
IQ - Iraq 28
MX - Messico 25
JP - Giappone 23
PL - Polonia 23
BE - Belgio 20
PK - Pakistan 19
SA - Arabia Saudita 17
LT - Lituania 15
CI - Costa d'Avorio 14
ID - Indonesia 14
CL - Cile 13
AT - Austria 12
EC - Ecuador 11
NP - Nepal 11
UZ - Uzbekistan 11
CZ - Repubblica Ceca 10
KE - Kenya 10
VE - Venezuela 10
CO - Colombia 8
IR - Iran 8
MY - Malesia 8
NG - Nigeria 8
JO - Giordania 7
DO - Repubblica Dominicana 6
EU - Europa 6
HU - Ungheria 6
PE - Perù 6
TH - Thailandia 6
AZ - Azerbaigian 5
DK - Danimarca 5
GR - Grecia 5
IL - Israele 5
MA - Marocco 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CH - Svizzera 4
EG - Egitto 4
ET - Etiopia 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
BO - Bolivia 3
CR - Costa Rica 3
DZ - Algeria 3
GE - Georgia 3
KZ - Kazakistan 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
TN - Tunisia 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MW - Malawi 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GA - Gabon 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
Totale 15.077
Salva come PNG Salva come JPEG
Città #
Dallas 784
Dublin 726
Fairfield 692
Southend 639
Singapore 559
Ashburn 450
Santa Clara 372
Chandler 319
Jacksonville 309
Woodbridge 304
Moscow 283
Houston 264
Beijing 250
Hong Kong 250
Wilmington 248
Cambridge 241
Seattle 237
Hefei 214
Ann Arbor 179
San Jose 178
Seoul 170
Princeton 138
The Dalles 117
Ho Chi Minh City 101
Council Bluffs 97
Los Angeles 96
Nanjing 92
Siena 87
Lauterbourg 86
Helsinki 80
Hanoi 73
Johannesburg 56
Boardman 47
New York 47
Buffalo 46
Shanghai 44
London 43
Munich 43
San Diego 43
Nanchang 42
São Paulo 39
Milan 37
Dong Ket 36
San Mateo 30
Dearborn 27
Tianjin 27
Shenyang 26
Redondo Beach 25
Columbus 24
Da Nang 24
Izmir 24
Orem 24
Rome 24
Bengaluru 22
San Francisco 21
Brussels 20
Tokyo 20
Málaga 19
Redwood City 19
Warsaw 19
Düsseldorf 17
Hebei 17
Kunming 17
Chicago 16
Jiaxing 16
Montreal 16
Changsha 15
Denver 15
Rio de Janeiro 15
Toronto 15
Abidjan 14
Boston 14
Brooklyn 14
Turku 14
Venezia 14
Belo Horizonte 13
Frankfurt am Main 13
Poplar 13
Chennai 12
Florence 12
Haiphong 12
Manchester 12
Nuremberg 12
Riyadh 12
Amsterdam 11
Mumbai 11
Norwalk 11
Porto Alegre 11
Portsmouth 11
Stockholm 11
Bologna 10
Brasília 10
Fremont 10
Hangzhou 10
Atlanta 9
Guangzhou 9
Tashkent 9
Zhengzhou 9
Abuja 8
Barnet 8
Totale 10.051
Salva come PNG Salva come JPEG
Nome #
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 301
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone 266
Aromatase activity and bone loss in men 251
A non-synonymous TNFRSF11A variation increases NFkB activity and the severity of Paget's disease 245
Bazedoxifene for the prevention of postmenopausal osteoporosis 244
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. 240
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease 233
The association of body composition and sexhormones with quantitative ultrasound parameters at the calcaneus and phalanxes in elderly women. 230
Variation in Bone Turnover Markers in Professional Sport Players During Training is Mediated by Changes in Sclerostin Levels 221
ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor 221
The usefulness of quantitative ultrasound (QUS) measurements in the evaluation of skeletal status in newborns and in children 218
Endocrine actions of osteocalcin 216
Corretto uso dei marcatori del rimodellamento osseo 213
Aromatase activity and bone loss 211
Bone metabolism in men: role of aromatase activity 206
Longitudinal association between sex hormone levels, bone loss and bone turnover in elderly men. 201
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone 197
Mutation of PFN1 gene in an early onset, polyostotic Paget-like disease 196
The influence of weight and length at birth on bone status during childhood as evaluated by QUS 194
Appropriate models for novel osteoporosis drug discovery and future perspectives 193
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family 191
Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis 191
CALCITRIOLO E OSTEOPOROSI 189
The effects of zoledronic acid on serum lipids in multiple myeloma patients 187
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone 183
Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function 183
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene 180
Analysis of Usual Consumption of Vitamin D Among Adult Individuals in Italy 179
aromatase deficiency and male osteoporosis 177
Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy 173
Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease 173
Vescicole extracellulari e metabolismo osseo: ruolo e possibili implicazioni cliniche 172
Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis 172
Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men 171
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone 171
Update on the pathogenesis and genetics of Paget's disease of bone 170
Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status. 169
Update on the pharmacogenetics of the vitamin D receptor and osteoporosis 168
Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree 167
Prevalence of Paget’s disease of bone in Italy 166
Apporto nutrizionale di vitamina D in Italia [Feeding and vitamin D in Italy] 165
Mechanisms of impaired bone strength in type 1 and 2 diabetes 165
Infection by CagA-Positive Helicobacter pylori Strains and Bone Fragility: A Prospective Cohort Study 165
Paget's disease of bone: epidemiology, pathogenesis and pharmacotherapy 163
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 162
MicroRNAs in bone diseases 162
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis 159
Bone fragility in men: where are we? 157
Perspectives in the treatment and prevention of osteoporosis 157
Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis 156
Vitamin D Status in Paget Disease of Bone and Efficacy-Safety Profile of Cholecalciferol Treatment in Pagetic Patients with Hypovitaminosis D. 156
Ospemifene use in postmenopausal women 155
Identification of Single Nucleotide Polymorphisms (SNPs) contributing to bone mineral density and fractures: a DNA microarray based study 149
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women 148
Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders 146
Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review 145
Lasofoxifene: Evidence of its therapeutic value in osteoporosis 144
Recent advances in models for screening potential osteoporosis drugs 144
Dietary Vitamin D Intake in Italian Subjects: Validation of a Frequency Food Questionnaire (FFQ) 142
Role of Advanced Glycation End-Products and Oxidative Stress in Type-2-Diabetes-Induced Bone Fragility and Implications on Fracture Risk Stratification 141
Raloxifene in breast cancer prevention 139
Interleukin-6 trans-signaling and pathological low back pain in patients with Paget disease of bone 139
Vitamin D deficiency and primary hyperparathyroidism 136
Cortisol secretion, sensitivity, and activity are associated with hypertension in postmenopausal eucortisolemic women 136
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 135
Relationship of sex hormones with bone turnover markers, bone ultrasounds and BMD at multiple sites in men and women 134
Vitamin D Deficiency in COVID-19 Patients and Role of Calcifediol Supplementation 132
Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy 131
The Potential Role of miRNAs as New Biomarkers for Osteoporosis 130
Drug treatment strategies for paget’s disease: relieving pain and preventing progression 128
null 128
Current options for the treatment of Paget's disease of the bone 126
Micro-RNA expression profiling in Paget's disease of bone 122
MANAGEMENT STRATEGIES FOR OSTEOPOROSIS IN THE AGING MALE: FOCUS ON ZOLEDRONIC ACID 122
Emerging therapeutic targets for osteoporosis 122
null 122
Diagnosis and treatment of Paget’s disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS) 121
Treatment options for glucocorticoid-induced osteoporosis 121
Professional sport activity and micronutrients: effects on bone mass 118
Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development 116
Paget’s disease of bone: an update on epidemiology, pathogenesis and pharmacotherapy 114
Paget's disease of bone 113
Efficacy and safety of abaloparatide for the treatment of post-menopausal osteoporosis 112
la genetica dell'osteoporosi 111
Clinical Characteristics and Evolution of Giant Cell Tumor Occurring in Paget's Disease of Bone 110
Oncogenic osteomalacia 108
Hypovitaminosis D and organ damage in patients with arterial hypertension: a multicenter double blind randomised controlled trial of cholecalciferol supplementation (HYPODD) : study design, clinical procedures and treatment protocol 107
Treatment needs and current options for postmenopausal osteoporosis 106
null 105
null 103
Management of bone fragility in type 2 diabetes:Perspective from an interdisciplinary expert panel 95
Energy metabolism and ketogenic diets: What about the skeletal health? a narrative review and a prospective vision for planning clinical trials on this issue 88
Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility 86
Validation of the clinical consensus recommendations on the management of fracture risk in postmenopausal women with type 2 diabetes 85
Prediction of hypertension, diabetes and fractures in eucortisolemic women by measuring parameters of cortisol milieu 83
Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis 73
Totale 15.267
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.459
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021276 0 0 0 0 0 0 0 0 0 93 96 87
2021/2022855 52 107 41 109 24 25 36 23 44 105 88 201
2022/20231.233 81 90 184 164 120 262 26 95 117 33 40 21
2023/20241.157 123 48 112 45 19 245 389 17 7 28 33 91
2024/20252.610 47 128 188 128 382 189 96 149 234 121 243 705
2025/20264.996 503 863 566 643 978 252 555 151 185 300 0 0
Totale 15.267